WeightWatchers GLP-1 Clinic Review WeightWatchers GLP-1 Clinic Review
Post Content Post Content
Prescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or ObesityPrescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or Obesity
This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity. This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity.
GLP-1RAs and Pay-Per-Click Direct-to-Consumer AdvertisingGLP-1RAs and Pay-Per-Click Direct-to-Consumer Advertising
This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA). This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA).
Chicago father of child fighting cancer released on bond by immigration judgeChicago father of child fighting cancer released on bond by immigration judge
A Chicago man whose 16-year-old daughter is undergoing treatment for advanced cancer will be released on bond and return home, an immigration judge ruled Thursday
Study Homes In on Breast Cancer Risk With Hormonal Birth ControlStudy Homes In on Breast Cancer Risk With Hormonal Birth Control
(MedPage Today) — Use of hormonal contraceptives was associated with an increased risk of breast cancer, but the risk varied by progestin content, according to a large Swedish cohort study.
Among over 2 million adolescent girls and women, ever…
Meet “The Pink Jet” aviators on a mission to empower breast cancer patientsMeet “The Pink Jet” aviators on a mission to empower breast cancer patients
“The Pink Jet,” a nonprofit organization, is on a new mission to empower those battling breast cancer, promote screenings and raise money to find a cure. CBS News’ Natalie Morales has more.
Breast cancer risk varies between different hormonal contraceptives, research revealsBreast cancer risk varies between different hormonal contraceptives, research reveals
Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and teenage girls in Sweden to identify how different hormonal contraceptives affect the risk of breast cancer.
GLP-1 drugs effective for weight loss, but more independent studies neededGLP-1 drugs effective for weight loss, but more independent studies needed
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity. Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically Read More
Postdiagnosis Statin Use and Breast Cancer MortalityPostdiagnosis Statin Use and Breast Cancer Mortality
This cohort study evaluates the association between postdiagnosis statin initiation and breast cancer mortality using an emulated target trial approach.
Capturing cancer cells from blood could help doctors choose the right breast cancer treatmentCapturing cancer cells from blood could help doctors choose the right breast cancer treatment
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients’ blood, research from the University of Michigan and the University of Kansas suggests.